Fasting cholesterol =< 300 mg/dL and triglycerides =< 2.5 x IULN obtained within 28 days prior to registration; patients may be on lipid lowering agents to reach these valuesXx_NEWLINE_xXTREATMENT: For patients on everolimus, fasting serum cholesterol =< 300 mg/dL OR =< 7.75 mmol/L AND fasting triglycerides =< 2.5 x upper limit of normal (ULN); NOTE: in case one or both of these thresholds are exceeded, the patient can receive everolimus on study only after initiation of appropriate lipid lowering medication with follow up documentation of values below the above cut-offXx_NEWLINE_xXFasting triglycerides =< 300 mg/dLXx_NEWLINE_xXMetabolic: fasting serum glucose (=< 130 mg/dL) and fasting triglycerides =< 300 mg/dLXx_NEWLINE_xXFasting triglycerides =< 300 mg/dLXx_NEWLINE_xXFasting triglycerides =< 300 mg/dL (3.42 mmol/L)Xx_NEWLINE_xXFasting cholesterol less than or equal to 300 mg/dl; fasting triglycerides less than or equal to 300 mg/dlXx_NEWLINE_xXWithin less than or equal to 14 days prior to registration: Fasting triglycerides =< 300 mg/dLXx_NEWLINE_xX